Rafael Amado
President, Head of Global Oncology Research and Development · Zai Lab Ltd
- 2025
- Apr 8, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rafael Amado files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ying Du - $8.58M in ZLAB purchases and sales in the last 12 months
- Frazor Titus Edmondson III - $1.01M in ZLAB purchases and sales in the last 12 months
- William Lis - $340K in ZLAB purchases and sales in the last 12 months
- Joshua L. Smiley - $294K in ZLAB purchases and sales in the last 12 months
- Yajing Chen - $224K in ZLAB purchases and sales in the last 12 months
- Richard Gaynor - $66K in ZLAB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rafael Amado?
Rafael Amado is a corporate insider, tracked as President, Head of Global Oncology Research and Development of Zai Lab Ltd (ZLAB). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Rafael Amado last file a Form 4?
The most recent primary Form 4 on record is dated 8 April 2026, one of 6 filings going back to 2025.
Has Rafael Amado been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($780K) across all tracked filings.
